As of close of business last night, Xerox Holdings Corp’s stock clocked out at $16.70, down -0.36% from its previous closing price of $16.76. In other words, the price has decreased by -$0.06 from its previous closing price. On the day, 3475981 shares were traded.
Ratios:
To gain a deeper understanding of XRX’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.52 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.20. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 1.14. In the meantime, Its Debt-to-Equity ratio is 1.26 whereas as Long-Term Debt/Eq ratio is at 1.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Credit Suisse on August 17, 2022, initiated with a Underperform rating and assigned the stock a target price of $14.
On February 04, 2021, Morgan Stanley Downgraded its rating to Underweight which previously was Equal-Weight but kept the price unchanged to $18.
Credit Suisse Downgraded its Outperform to Neutral on January 27, 2021, whereas the target price for the stock was revised from $23 to $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 28 ’23 when ICAHN CARL C sold 34,245,314 shares for $15.84 per share. The transaction valued at 542,445,774 led to the insider holds 0 shares of the business.
Morno-Wade Suzan sold 9,126 shares of XRX for $152,898 on Sep 05 ’23. The EVP & CHRO now owns 46,323 shares after completing the transaction at $16.75 per share. On Aug 09 ’23, another insider, BANDROWCZAK STEVEN JOHN, who serves as the Chief Executive Officer of the company, sold 135,000 shares for $15.53 each. As a result, the insider received 2,096,550 and left with 110,557 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XRX now has a Market Capitalization of 2.07B and an Enterprise Value of 5.23B. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.30 while its Price-to-Book (P/B) ratio in mrq is 0.81. Its current Enterprise Value per Revenue stands at 0.76 whereas that against EBITDA is 17.96.
Stock Price History:
Over the past 52 weeks, XRX has reached a high of $19.78, while it has fallen to a 52-week low of $12.06. The 50-Day Moving Average of the stock is 17.78, while the 200-Day Moving Average is calculated to be 15.78.
Shares Statistics:
It appears that XRX traded 2.50M shares on average per day over the past three months and 3.1M shares per day over the past ten days. A total of 123.14M shares are outstanding, with a floating share count of 114.80M. Insiders hold about 7.56% of the company’s shares, while institutions hold 86.58% stake in the company. Shares short for XRX as of Feb 15, 2024 were 9.52M with a Short Ratio of 3.80, compared to 10.41M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.66% and a Short% of Float of 11.78%.
Dividends & Splits
With its trailing 12-month dividend rate of 1.00, XRX has a forward annual dividend rate of 1.00. Against a Trailing Annual Dividend Yield of 5.97%, it implies a Forward Annual Dividend Yield of 5.99%. The stock’s 5-year Average Dividend Yield is 5.11.
Earnings Estimates
As of right now, 3 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.35 for the current quarter, with a high estimate of $0.38 and a low estimate of $0.29, while EPS last year was $0.49. The consensus estimate for the next quarter is $0.45, with high estimates of $0.51 and low estimates of $0.34.
Analysts are recommending an EPS of between $2.23 and $2.03 for the fiscal current year, implying an average EPS of $2.15. EPS for the following year is $2.43, with 2 analysts recommending between $2.5 and $2.36.
Revenue Estimates
In the current quarter, 2 analysts expect revenue to total $1.53B. It ranges from a high estimate of $1.57B to a low estimate of $1.5B. As of the current estimate, Xerox Holdings Corp’s year-ago sales were $1.72B, an estimated decrease of -11.00% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $1.64B, a decrease of -6.60% over than the figure of -$11.00% in the same quarter last year. There is a high estimate of $1.64B for the next quarter, whereas the lowest estimate is $1.64B.
A total of 4 analysts have provided revenue estimates for XRX’s current fiscal year. The highest revenue estimate was $6.75B, while the lowest revenue estimate was $6.49B, resulting in an average revenue estimate of $6.59B. In the same quarter a year ago, actual revenue was $6.89B, down -4.30% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $6.5B in the next fiscal year. The high estimate is $6.63B and the low estimate is $6.41B. The average revenue growth estimate for next year is down -1.30% from the average revenue estimate for this year.
